The overall median survivalwas 19.9 ± 0.81 months compared with 18.4 ± 0.79 in the control group, p = 0.67; Meanprogression-free survival (PFS) was 18.5± 0.89 months compared with 17.2± 0.90 in the control group, p = 0.59.